SS Innovations International, Inc.
General ticker "SSII" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.1B (TTM average)
SS Innovations International, Inc. does not follow the US Stock Market performance with the rate: -23.3%.
Estimated limits based on current volatility of 4.2%: low 3.28$, high 3.56$
Factors to consider:
- Total employees count: 6 as of 2017
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.91$, 7.56$]
- 2026-12-31 to 2027-12-31 estimated range: [0.89$, 4.02$]
Financial Metrics affecting the SSII estimates:
- Positive: with PPE of -92.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.34 > -0.60
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
- Positive: Inventory ratio change, % of -5.67 <= -0.75
- Positive: 42.59 < Shareholder equity ratio, % of 51.49 <= 64.29
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.10 <= 0.73
Short-term SSII quotes
Long-term SSII plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $5.88MM | $20.65MM | $42.48MM |
| Operating Expenses | $26.15MM | $39.63MM | $50.68MM |
| Operating Income | $-20.27MM | $-18.98MM | $-8.19MM |
| Non-Operating Income | $-0.60MM | $-0.18MM | $0.03MM |
| Interest Expense | $0.89MM | $0.97MM | $1.11MM |
| R&D Expense | $1.06MM | $2.49MM | $3.69MM |
| Income(Loss) | $-20.88MM | $-19.15MM | $-8.16MM |
| Taxes | $0.00MM | $0.00MM | $3.97MM |
| Net Income(Loss)* | $-20.94MM | $-19.15MM | $-12.13MM |
| Stockholders Equity | $19.72MM | $13.46MM | $38.22MM |
| Inventory | $6.33MM | $10.21MM | $17.06MM |
| Assets | $31.52MM | $42.39MM | $74.23MM |
| Operating Cash Flow | $-15.36MM | $-9.50MM | $-18.54MM |
| Capital expenditure | $0.45MM | $0.66MM | $3.66MM |
| Investing Cash Flow | $-0.45MM | $-0.66MM | $-3.66MM |
| Financing Cash Flow | $22.80MM | $9.43MM | $26.17MM |
| Earnings Per Share** | $-0.16 | $-0.11 | $-0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.